您要查找的是不是：
- Cholestatic liver fibrosis 胆汁淤积性肝纤维化
- Useful in vivo models for testing of antifibrotics are rat secondary biliary fibrosis or the MDR2 KO mouse (chronic cholestatic liver disease)and reversion of fibrosis after withdrawal of a hepatotoxin like thioacetamide. 用于检测抗肝纤维化药物有效性的动物模型包括继发性大鼠胆汁性肝纤维化或者MDR2 KO小鼠模型(慢性淤胆性肝病)以及撤药以后可逆性的肝毒性肝纤维化如硫代乙酰胺肝纤维化模型。
- Hepatology Digest: Cholestatic liver disease is a rare chronic liver disease. 国际肝病: 胆汁淤积性肝病是一种罕见的慢性肝病。
- CCB has definitely therapeutic effect on liver fibrosis. CCB对肝纤维化有治疗作用。
- BDD has the function of anti experimental liver fibrosis. 活血渗湿方具有显著的抗实验性肝纤维化的作用
- Staging Liver Fibrosis: Time to Abandon Liver Biopsy? 肝纤维化的分期：是该抛弃肝脏活检的时候了?
- Hepatology Digest: Would you please give us some advice on how to treat patients with Cholestatic liver disease? 国际肝病:能否请您就如何治疗胆汁淤积性肝病患者给我们一些建议？
- Would you please talk about the potential mechanisms in the treatment of cholestatic liver disease? 能否请您谈一下胆汁淤积性肝病治疗中的潜在机制？
- In this paper,the application of ursodeoxycholic acid in cholestatic liver diseases has been discussed. 此文就熊去氧胆酸在胆汁淤积性肝病的应用作一综述。
- Hepatology Digest: The nuclear receptors are important in cholestatic liver disease. 国际肝病: 核受体在胆汁淤积性肝病很重要。
- Objective Observation of the serum in patients with chronic liver fibrosis. 目的观察慢性肝病患者的血清纤维化指标。
- Hepatology Digest: Cholestatic liver disease is a rare chronic liver disease. Would you please give us a brief introduction about its pathogenesis? 国际肝病:胆汁淤积性肝病是一种罕见的慢性肝病。能否请您就其发病机理为我们做一简单介绍？
- Objcet: To observe the effect of "Man-Gan-Fu" in treating liver fibrosis. 目的：观察中药慢肝福治疗肝纤维化的效果。
- Progressive familial intrahepatic cholestasis (PFIC) is a severe cholestatic liver disease of early life often requiring liver transplantation. 进行性家族性肝内胆汁淤积（PFIC）是生命早期一种严重的肝胆疾病，通常需要进行肝脏移植。
- The ERK signaling pathway is involved in liver fibrosis in many ways. 近年来发现其与肝纤维化的关系密切,可从多方面影响肝纤维化的形成。
- Objective:To define the therapeutic effect of BDD s anti liver fibrosis. 目的:确定活血渗湿方抗实验性肝纤维化的疗效。
- The PDR for Herbal Medicines states that licorice is contraindicated (use is inadvisable) in people with chronic hepatitis, cholestatic liver disease, and cirrhosis. 国际医生手则（PDR）在草药部分规定，禁忌对患有慢性肝炎、胆汁淤积性肝病和肝硬化的人使用甘草。
- Systemic mastocytosis results in the accumulation of mast cells in various tissues.We report a rare case of systemic mastocytosis presenting with cholestatic liver disease. 系统性肥大导致肥大细胞在各组织中的集聚，我们报告一例罕见的系统性肥大症与胆汁淤积性肝病。
- ABSTRACT Purpose To evaluate the effect of hepatocyte(HC) on liver fibrosis. 摘要 目的：探索肝细胞在肝纤维化形成中的可能作用。
- METHODS The liver fibrosis model in rats was established by using DMN. 目的观察沙苑子黄酮对二甲基亚硝胺(DMN)诱导的大鼠肝纤维化形成的影响。
